02.07.20 ijBio Portfolio

Pharm Involved.

$1,000,000 on 12.06.20 Changes for 02.07.20:

AstraZeneca (AZN) $51,3 $53,8 (+4.9%) $104,900

Inovio (INO) $13,2 $21,4 (+62.1%) $162,100

Moderna (MRNA)$61,5 $58,6 (-4.7%) $95,300

Abbot (ABT) $88,5 $92,2 (+4.1%) $104,100

Gilead (GILD) $72,5 $76,3 (+4.8%) $104,800

Adaptive (ADPT) $42,2.  $47,5 (+12.5%) $112,500

CytoDyn (CYDY) $3,12 $6 (+92.3%) $192,300

AbbVie (ABBV) $92,2 $99 (+7.5%) $107,500

Arcus (RCUS) $27,3 $24 (-12%) $88,000

Sorrento (SRNE) $4,6  $6,85 (+49%) $149,000

At close 02.07.20= $1,220,500 (- 0,9%)

per million dollars at 10% per share.

previous day

At close 01.07.20= $1,232,200 (-1.6%)

At close 30.06.20= $1,252,700 (-7,9%)

At close 29.06.20= $1,361,400 (+6,4%)

At close 26.06.20= $1,279,600

during the two weeks 12-26.06.2020:+28% and

during the week 19-26.06.2020:+21%

At close 19.06.20= $1,057,700

during the week 12-19.06 +6%

12.06.20 = $1,000,000

Global Communication Platforms portfoilio

--

Portfolio News:

Dow Jones Futures: Coronavirus Stock Market Rally Fades, But Four New Breakouts; What's Next For Tesla

Pomerantz Law Firm Announces the Filing of a Class Action against Co-Diagnostics, Inc. and Certain Officers - CODX

How Moderna executives are cashing in on COVID-19 vaccine stock speculation

Regeneron, Sanofi arthritis drug fails COVID-19 study

Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses

US Indexes Close Higher to End the Shortened Week

Invesco European Growth Fund's Top 2nd-Quarter Trades

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Were Hedge Funds Right About Buying Gilead Sciences, Inc. (GILD)?

Were Hedge Funds Right About Merck & Co., Inc. (MRK)?

Were Hedge Funds Right About Piling Into AbbVie Inc (ABBV)?

Were Hedge Funds Right About Cutting Johnson & Johnson (JNJ)?

Were Hedge Funds Right About Buying Pfizer Inc. (PFE)?

INSIGHT-How Moderna execs are cashing in on COVID-19 vaccine stock speculation

Abbott Laboratories (ABT): Were Hedge Funds Right About This Stock?

Stock Market Today: Double Dose of Jobs Data Drives Stocks Higher

Regeneron, Sanofi halt trial for experimental coronavirus drug, shares fall

The Number of Covid-19 Cases Is Rising. What Comes Next.

Infojet Club

With help but without the assistance of Yahoo Finance

Advertise With Us